Retraction: Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer

🔗 원문 전체 보기 → Royal Society of Chemistry

요약

RSC Adv., 2026, 16,29153-29153DOI: 10.1039/D6RA90056A, Retraction Open Access &nbsp This article is licensed under a Creative Commons Attribution 3.0 Unported Licence.Norah F. Alqahtani, Mohammad Y. Alfaifi, Ali Shati A, Serag Eldin I. Elbehairi, Abdulrahman …

본문

Retraction: Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer

* Corresponding authors

a Department of Chemistry, College of Science, University of Jeddah, Jeddah 21589, Saudi Arabia

b King Khalid University, Faculty of Science, Biology Department, Abha 9004, Saudi Arabia

c Tissue Culture and Cancer Biology Research Laboratory, King Khalid University, Abha, Saudi Arabia

d Cell Culture Lab, Egyptian Organization for Biological Products and Vaccines (VACSERA Holding Company), 51 Wezaret El-Zeraa St., Agouza, Giza, Egypt

e Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt

f Aweash El-Hagar Family Medicine Center, Epidemiological Surveillance Unit, MOHP, Mansoura 35711, Egypt

g Department of Chemistry, Faculty of Science, Suez University, 43533 Suez, Egypt
E-mail: [email protected]

h Institut für Anorganische Chemie und Strukturchemie, Heinrich-Heine Universität Düsseldorf, Düsseldorf, Germany

i College of Sciences, Biology Department, King Khalid University, Abha 61413, Saudi Arabia

j Department of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, Egypt

k Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, Al-Kitab University, Kirkuk, Iraq

Abstract

Retraction of ‘Molecular docking and in vivo/in vitro studies of a novel thiadiazole Schiff base as a hepatoprotective drug against angiogenesis induced by breast cancer’ by Norah F. Alqahtani et al., RSC Adv., 2024, 14, 39027–39039, https://doi.org/10.1039/D4RA06398H.